SCHEMBL8796385

SCHEMBL8796385

O=[C]c1ccc(C(=O)O)cc1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 5/20 0.55
NR4A1 P22736 1/20 0.51
TSHR P16473 2/20 0.50
ALOX15 P16050 1/20 0.50
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42
CDH1 P12830 1/20 0.41
APC P25054 1/20 0.41
CTNNB1 P35222 1/20 0.41
TCF7L2 Q9NQB0 1/20 0.41
SRD5A1 P18405 1/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2C9 P11712 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
FNTA P49354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9712382 0.83 RAB9A (0.48) SRD5A2NR4A1MEN1KMT2AALDH1A1
SCHEMBL9712369 0.83 MDM2 (0.47) SRD5A2NR4A1MEN1KMT2AMAPK1
SCHEMBL3154810 0.82 ALDH1A1 (0.52) SRD5A2NR4A1ALOX15MEN1KMT2A
SCHEMBL6977856 0.82 KDM4E (0.53) SRD5A2KDM4EMEN1KMT2APOLB
SCHEMBL9712544 0.82 NR4A1 (0.50) SRD5A2NR4A1KDM4EMEN1KMT2A
SCHEMBL7293957 0.81 KDM4E (0.48) SRD5A2TSHRKDM4EALDH1A1POLB
SCHEMBL28775847 0.80 KDM4E (0.73) SRD5A2NR4A1TSHRALOX15KDM4E
SCHEMBL10934884 0.79 POLB (0.68) MEN1KMT2AALDH1A1MAPK1RAB9A
SCHEMBL9130311 0.78 NR4A1 (0.61) SRD5A2NR4A1KDM4EMEN1KMT2A
SCHEMBL9712508 0.77 GAA (0.49) SRD5A2MEN1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0810209-A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed